APL Bioengineering is devoted to research at the intersection of biology, physics, and engineering. The journal publishes high-impact manuscripts specific to the understanding and advancement of physics and engineering of biological systems. APL Bioengineering is the new home for the bioengineering and biomedical research communities.

APL Bioengineering publishes original research articles and invited Reviews and Perspectives. For more information regarding format and content types, please visit our Editorial Policies page.

Topical coverage includes:

  • Biofabrication and Bioprinting
  • Biomedical Materials, Sensors, and Imaging
  • Engineered Living Systems
  • Cell and Tissue Engineering
  • Regenerative Medicine
  • Molecular, Cell, and Tissue Biomechanics
  • Systems Biology and Computational Biology

Open Access Statement

APL Bioengineering is an open access journal. Articles published in APL Bioengineering are freely accessible, without restrictions, to the global public. Authors who publish in APL Bioengineering retain the copyright to their work under a Creative Commons license. Under this license, users are free to share and adapt the material in any format, provided appropriate credit is given. Visit the AIP Publishing Open Access Policy for more information about our policies on open access.

2022 Journal Citation Reports® (Clarivate, 2023)*:

Five-Year Impact Factor

6.1

Impact Factor

6.0

Immediacy Index

1.4

Cited Half-Life

2.6

Eigenfactor Score

0.00217

Article Influence Score

1.211

Total Citations

1,299

* Data from the 2022 Journal Citation Reports® Science Edition (Clarivate, 2023).

ISSN: 2473-2877
CODEN: ABPID9